Tesaro, Inc. Sustainability Profile
Tesaro, Inc., a prominent biopharmaceutical company headquartered in the United States, is dedicated to advancing cancer treatment through innovative therapies. Founded in 2010, Tesaro has made significant strides in the oncology sector, particularly in the development of targeted therapies and immuno-oncology solutions. The company’s flagship product, Zejula (niraparib), is a groundbreaking treatment for ovarian cancer, distinguished by its ability to provide maintenance therapy for patients with recurrent disease. Tesaro's commitment to research and development has positioned it as a leader in the oncology market, with a focus on improving patient outcomes and quality of life. With a strong presence in North America and Europe, Tesaro continues to expand its portfolio, aiming to address unmet medical needs in cancer care. Its dedication to innovation and patient-centric solutions underscores its reputation as a key player in the biopharmaceutical industry.
DitchCarbon Score
How does Tesaro, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tesaro, Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tesaro, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of GSK plc, which means that any climate commitments or emissions data may be inherited from its parent organisation. As part of its climate strategy, Tesaro, Inc. aligns with GSK plc's initiatives, which include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative. These initiatives aim to significantly reduce carbon emissions and transition to renewable energy sources. However, specific reduction targets or achievements for Tesaro, Inc. have not been disclosed. In summary, while Tesaro, Inc. does not provide its own emissions data, it is committed to climate action through its association with GSK plc, which sets the framework for its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,040,928,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 788,149,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 16,630,521,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
How Carbon Intensive is Tesaro, Inc.'s Industry?
How Carbon Intensive is Tesaro, Inc.'s Location?
Tesaro, Inc.'s Scope 3 Categories Breakdown
Tesaro, Inc.'s Scope 3 emissions, which decreased by 0% last year and decreased by approximately 46% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 56% of Scope 3 emissions.
Top Scope 3 Categories
Tesaro, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tesaro, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
